NEXTSTELLIS® revenue was US$14.1m vs US$4.2m in FY22 with sales momentum building. Dispensed cycles were up 2.5x July 2023 v July 2022 and up 80% in 2HFY23 vs 1HFY23 attributable to the positive impact of our refreshed leadership and marketing strategy.2 days agoMore than 3 fold revenue growth proves the company strategy success , with 75% reduction in marketing costs YOY , with the same rate , FY24 could reach 45 m to 50 Mil THEN so yes they are on the path to profitability . all indictors are positive .Share price outlook , if after the feb update that was 97 m worse the price reached 4.9 then after the +ve update expect 6 to 7 to 8.85 as per gauldman schs analysts
- Forums
- ASX - By Stock
- MYX
- mayne market cap expected to grow to 1 b
MYX
mayne pharma group limited
Add to My Watchlist
1.57%
!
$5.00

mayne market cap expected to grow to 1 b, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.00 |
Change
-0.080(1.57%) |
Mkt cap ! $406.2M |
Open | High | Low | Value | Volume |
$5.08 | $5.10 | $4.95 | $1.426M | 285.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50 | $5.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.02 | 259 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 7653 | 4.960 |
2 | 971 | 4.940 |
1 | 753 | 4.930 |
1 | 753 | 4.910 |
2 | 12000 | 4.900 |
Price($) | Vol. | No. |
---|---|---|
5.020 | 259 | 1 |
5.060 | 256 | 1 |
5.070 | 753 | 1 |
5.090 | 251 | 1 |
5.100 | 7653 | 5 |
Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |